Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole

Autor: Winston D. Byblow, April Ren, Justin Kao, Barry Snow, James P. Coxon, Hayley J. MacDonald, Steven C. Cramer, Lorraine Macdonald, Cathy M. Stinear
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Adult
Male
Indoles
Cognitive Neuroscience
Dopamine Plasma Membrane Transport Proteins
Decision Making
Pharmacology
Stop signal
Motor Activity
Catechol O-Methyltransferase
Dopamine agonist
Polymorphism
Single Nucleotide

Developmental psychology
03 medical and health sciences
0302 clinical medicine
Double-Blind Method
Dopamine
medicine
Reaction Time
Humans
Psychology
Genetic Predisposition to Disease
Dopamine transporter
Aged
Catechol-O-methyl transferase
biology
Dose-Response Relationship
Drug

Receptors
Dopamine D2

Receptors
Dopamine D1

Receptors
Dopamine D3

Neurosciences
Experimental Psychology
Middle Aged
Impulse control
030104 developmental biology
Ropinirole
Dopamine Agonists
Impulsive Behavior
biology.protein
Female
Cognitive Sciences
030217 neurology & neurosurgery
medicine.drug
Zdroj: MacDonald, Hayley J; Stinear, Cathy M; Ren, April; Coxon, James P; Kao, Justin; Macdonald, Lorraine; et al.(2016). Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole.. Journal of cognitive neuroscience, 28(7), 909-919. doi: 10.1162/jocn_a_00946. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/9b04v7tk
DOI: 10.1162/jocn_a_00946.
Popis: Dopamine agonists can impair inhibitory control and cause impulse control disorders for those with Parkinson disease (PD), although mechanistically this is not well understood. In this study, we hypothesized that the extent of such drug effects on impulse control is related to specific dopamine gene polymorphisms. This double-blind, placebo-controlled study aimed to examine the effect of single doses of 0.5 and 1.0 mg of the dopamine agonist ropinirole on impulse control in healthy adults of typical age for PD onset. Impulse control was measured by stop signal RT on a response inhibition task and by an index of impulsive decision-making on the Balloon Analogue Risk Task. A dopamine genetic risk score quantified basal dopamine neurotransmission from the influence of five genes: catechol-O-methyltransferase, dopamine transporter, and those encoding receptors D1, D2, and D3. With placebo, impulse control was better for the high versus low genetic risk score groups. Ropinirole modulated impulse control in a manner dependent on genetic risk score. For the lower score group, both doses improved response inhibition (decreased stop signal RT) whereas the lower dose reduced impulsiveness in decision-making. Conversely, the higher score group showed a trend for worsened response inhibition on the lower dose whereas both doses increased impulsiveness in decision-making. The implications of the present findings are that genotyping can be used to predict impulse control and whether it will improve or worsen with the administration of dopamine agonists.
Databáze: OpenAIRE